| For: | Baird AC, Mallon D, Radford-Smith G, Boyer J, Piche T, Prescott SL, Lawrance IC, Tulic MK. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy. World J Gastroenterol 2016; 22(41): 9104-9116 [PMID: 27895398 DOI: 10.3748/wjg.v22.i41.9104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9104.htm |
| Number | Citing Articles |
| 1 |
Mohammed N. Khan, Majella E. Lane, Paul A. McCarron, Murtaza M. Tambuwala. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function. Inflammopharmacology 2018; 26(2) doi: 10.1007/s10787-017-0364-x
|
| 2 |
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen, Shenghong Zhang. Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00123
|
| 3 |
Christopher G Fenton, Hagar Taman, Jon Florholmen, Sveinung W Sørbye, Ruth H Paulssen. Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflammatory Bowel Diseases 2021; 27(1) doi: 10.1093/ibd/izaa075
|
| 4 |
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, A. V. Borisova, E. V. Kruchinina. The significance of serum marker levels for assessing the status and prognosis of patients with inflammatory bowel disease. Experimental and Clinical Gastroenterology 2023; (4) doi: 10.31146/1682-8658-ecg-212-4-121-132
|
| 5 |
Guoqiang Fan, Yaxin Liu, Limei Tao, Danping Wang, Yizhu Huang, Xiaojing Yang. Sodium butyrate alleviates colitis by inhibiting mitochondrial ROS mediated macrophage pyroptosis. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2025; 1871(5) doi: 10.1016/j.bbadis.2025.167756
|
| 6 |
Sabine Ivison, Christine Des Rosiers, Sylvie Lesage, John D Rioux, Megan K Levings. Biomarker-guided stratification of autoimmune patients for biologic therapy. Current Opinion in Immunology 2017; 49 doi: 10.1016/j.coi.2017.09.006
|
| 7 |
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23136966
|
| 8 |
Fereshte Abdolmaleki, Najmeh Farahani, Seyed Mohammad Gheibi Hayat, Matteo Pirro, Vanessa Bianconi, George E. Barreto, Amirhossein Sahebkar. The Role of Efferocytosis in Autoimmune Diseases. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01645
|
| 9 |
Javier P Gisbert, María Chaparro. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. Journal of Crohn's and Colitis 2020; 14(5) doi: 10.1093/ecco-jcc/jjz195
|
| 10 |
Toer W. Stevens, Mijntje Matheeuwsen, Maria H. Lönnkvist, Claire E. Parker, Manon E. Wildenberg, Krisztina B. Gecse, Geert R. D’Haens. Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy. Alimentary Pharmacology & Therapeutics 2018; 48(11-12) doi: 10.1111/apt.15033
|
| 11 |
Federica Giachero, Andreas Jenke, Matthias Zilbauer. Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 2021; 17(8) doi: 10.1080/1744666X.2021.1945442
|
| 12 |
A. Lekic, Z. Brekalo, A. Kvesic, M. Kovacevic, Z. Baricev‐Novakovic, I. Sutic, A. Bulog, I. Sutic, V. Pavisic, I. Mrakovcic‐Sutic. Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis. Scandinavian Journal of Immunology 2017; 86(1) doi: 10.1111/sji.12563
|
| 13 |
Jian Shen, Jiazheng Cheng, Shengguo Zhu, Jun Zhao, Qingyan Ye, Yinyin Xu, Huilin Dong, Xianhui Zheng. Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis. International Immunopharmacology 2019; 73 doi: 10.1016/j.intimp.2019.04.052
|
| 14 |
Wanling Li, Yaqing Huang, Jun Liu, Yue Zhou, Hongyu Sun, Yonghong Fan, Feila Liu. Defective macrophage efferocytosis in advanced atherosclerotic plaque and mitochondrial therapy. Life Sciences 2024; 359 doi: 10.1016/j.lfs.2024.123204
|
| 15 |
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 2021; 44(3) doi: 10.1007/s12272-021-01318-6
|
| 16 |
Franklin Chu Buh, Germain Sotoing Taiwe, Andrew I. R. Maas, Mathieu Motah, Ignatius Esene, Firas H. Kobeissy, Vanessa Tita Jugha, Eric Youm, Basil Kum Meh, Kevin W. Wang, Peter J. A. Hutchinson, Irene Ule Ngole Sumbele. Concurrent Toxoplasma gondii infection and neuroinflammation in traumatic brain injury patients in a referral hospital in Douala Cameroon. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-40284-1
|
| 17 |
Yun Ge, Man Huang, Yong-ming Yao. Efferocytosis and Its Role in Inflammatory Disorders. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.839248
|
| 18 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231173331
|
| 19 |
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt, Garret Cullen. ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(10) doi: 10.1093/ecco-jcc/jjab112
|
| 20 |
Hiroshi Nakase, Noriko Sato, Naomi Mizuno, Yoshiko Ikawa. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Reviews 2022; 21(3) doi: 10.1016/j.autrev.2021.103017
|
| 21 |
Yue Zhang, Takeshi Yamamoto, Shusaku Hayashi, Makoto Kadowaki. Suppression of plasmacytoid dendritic cell migration to colonic isolated lymphoid follicles abrogates the development of colitis. Biomedicine & Pharmacotherapy 2021; 141 doi: 10.1016/j.biopha.2021.111881
|
| 22 |
Raja Atreya, Markus F. Neurath, Britta Siegmund. Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00517
|
| 23 |
Panagiotis G. Doukas, Sotirios G. Doukas, Arkady Broder. Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis. Digestive Diseases 2025; 44(1) doi: 10.1159/000548568
|